PROSHARE ADVISORS LLC – Vertex Pharmaceuticals Incorporated Transaction History
PROSHARE ADVISORS LLC portfolio value:
$81.56M
portfolio value
PROSHARE ADVISORS LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.72% | -48.61K shares | -11.51M | $289.54 | 281.71K |
| Q2 2022 | share | Decrease | -32.45% | -158.65K shares | -34.52M | $281.79 | 330.32K |
| Q1 2022 | share | Decrease | -5.46% | -28.21K shares | 14.03M | $260.97 | 488.97K |
| Q4 2021 | share | Increase | +38.60% | 144.03K shares | 45.88M | $222.45 | 517.18K |
| Q3 2021 | share | Increase | +9.87% | 33.51K shares | -794K | $181.39 | 373.15K |
| Q2 2021 | share | Decrease | -1.47% | -5.06K shares | -5.59M | $201.63 | 339.63K |
| Q1 2021 | share | Increase | +15.00% | 44.96K shares | 3.23M | $214.89 | 344.70K |
| Q4 2020 | share | Increase | +14.11% | 37.06K shares | -638K | $236.34 | 299.73K |
| Q3 2020 | share | Increase | +15.30% | 34.84K shares | 5.33M | $272.12 | 262.67K |
| Q2 2020 | share | Increase | +13.62% | 27.30K shares | 18.42M | $290.31 | 227.82K |
| Q1 2020 | share | Decrease | -29.93% | -85.64K shares | -14.94M | $237.95 | 200.51K |
| Q4 2019 | share | Increase | +4.97% | 13.55K shares | 16.46M | $218.95 | 286.15K |
| Q3 2019 | share | Increase | +1.73% | 4.64K shares | -2.95M | $169.42 | 272.60K |
| Q2 2019 | share | Decrease | -9.66% | -28.65K shares | -5.42M | $183.38 | 267.96K |
| Q1 2019 | share | Increase | +10.11% | 27.23K shares | 9.92M | $183.95 | 296.61K |
| Q4 2018 | share | Increase | +10.87% | 26.40K shares | -2.19M | $165.71 | 269.37K |
| Q3 2018 | share | Decrease | -9.38% | -25.16K shares | 1.25M | $192.74 | 242.97K |
| Q2 2018 | share | Decrease | -15.06% | -47.54K shares | -5.87M | $169.96 | 268.13K |
| Q1 2018 | share | Increase | +13.62% | 37.85K shares | 9.81M | $162.98 | 315.67K |
| Q4 2017 | share | Increase | +27.85% | 60.52K shares | 8.59M | $149.86 | 277.82K |
| Q3 2017 | share | Increase | +7.55% | 15.24K shares | 7M | $152.04 | 217.30K |
| Q2 2017 | share | Decrease | -8.20% | -18.04K shares | 1.97M | $128.87 | 202.05K |
| Q1 2017 | share | Decrease | -19.22% | -52.37K shares | 3.99M | $109.35 | 220.10K |
| Q4 2016 | share | Increase | +17.70% | 40.97K shares | -116K | $73.67 | 272.47K |
| Q3 2016 | share | Decrease | -20.49% | -59.67K shares | -4.85M | $87.21 | 231.49K |
| Q2 2016 | share | Increase | +1.96% | 5.59K shares | 2.34M | $86.02 | 291.16K |
| Q1 2016 | share | Decrease | -6.09% | -18.52K shares | -15.56M | $79.49 | 285.57K |